- Home
- Publications
- Publication Search
- Publication Details
Title
The Path Towards a Tailored Clinical Biosimilar Development
Authors
Keywords
-
Journal
BIODRUGS
Volume 34, Issue 3, Pages 297-306
Publisher
Springer Science and Business Media LLC
Online
2020-04-07
DOI
10.1007/s40259-020-00422-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differences in immunogenicity associated with non-product related variability: insights from two pharmacokinetic studies using GP2017, an adalimumab biosimilar
- (2019) Oliver von Richter et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Biological Characterization of SB3, a Trastuzumab Biosimilar, and the Influence of Changes in Reference Product Characteristics on the Similarity Assessment
- (2019) Jae Hee Lee et al. BIODRUGS
- Evolution of the EU Biosimilar Framework: Past and Future
- (2019) Elena Wolff-Holz et al. BIODRUGS
- An Efficient Development Paradigm for Biosimilars
- (2019) Christopher J. Webster et al. BIODRUGS
- Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies
- (2019) Junyi Li et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The End of Phase 3 Clinical Trials in Biosimilars Development?
- (2018) Francois-Xavier Frapaise BIODRUGS
- Therapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential
- (2018) Florian Cymer et al. BIOLOGICALS
- Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes
- (2018) Hillel P. Cohen et al. DRUGS
- International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab
- (2017) Sandra Prior et al. mAbs
- Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar
- (2017) Seokkyun Kim et al. mAbs
- Ten years of biosimilars in Europe: development and evolution of the regulatory pathways
- (2017) Martin Schiestl et al. Drug Design Development and Therapy
- Authorized manufacturing changes for therapeutic monoclonal antibodies (mAbs) in European Public Assessment Report (EPAR) documents
- (2016) Balázs Vezér et al. CURRENT MEDICAL RESEARCH AND OPINION
- Taking immunogenicity assessment of therapeutic proteins to the next level
- (2011) I.C. Büttel et al. BIOLOGICALS
- Acceptable changes in quality attributes of glycosylated biopharmaceuticals
- (2011) Martin Schiestl et al. NATURE BIOTECHNOLOGY
- Tungsten-Induced Denaturation and Aggregation of Epoetin Alfa During Primary Packaging as a Cause of Immunogenicity
- (2011) Andreas Seidl et al. PHARMACEUTICAL RESEARCH
- Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
- (2010) Satish Kumar Singh JOURNAL OF PHARMACEUTICAL SCIENCES
- Quality by design for biopharmaceuticals
- (2009) Anurag S Rathore et al. NATURE BIOTECHNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started